CN1043406C - Method for preparation of compound Qingdaisan powder - Google Patents

Method for preparation of compound Qingdaisan powder Download PDF

Info

Publication number
CN1043406C
CN1043406C CN93121590A CN93121590A CN1043406C CN 1043406 C CN1043406 C CN 1043406C CN 93121590 A CN93121590 A CN 93121590A CN 93121590 A CN93121590 A CN 93121590A CN 1043406 C CN1043406 C CN 1043406C
Authority
CN
China
Prior art keywords
qingdaisan
powder
thick paste
hours
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93121590A
Other languages
Chinese (zh)
Other versions
CN1094964A (en
Inventor
尚庆英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN93121590A priority Critical patent/CN1043406C/en
Publication of CN1094964A publication Critical patent/CN1094964A/en
Application granted granted Critical
Publication of CN1043406C publication Critical patent/CN1043406C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to compound qingdaisan which is prepared from nine Chinese herbal medicines, wherein alkaloids with effective curative effects of common cnidium fruit, golden thread, lightyellow sophora root, golden larch bark and folium syringae are extracted by different methods. After being crushed and sieved, calcined alum, catechu, realgar and bear gall are mixed with the alkaloids, sieved, dried, sterilized and packed in a separate way; then, the compound qingdaisan is prepared. The compound qingdaisan is used for treating various kinds of vaginitis and trachelitis of females; the females with diseases need adopting a drug powder applying device for cervixes offered in the China patent with the patent number of 92200616.4 to spray the medicine powder on uterine necks and in vaginae. Excipients do not need adding to the medicine, so the medicine of the present invention is favorable for realizing the curative effects.

Description

The preparation method of compound Qingdaisan powder
The present invention is a kind of preparation method of Chinese herb medicine, is the process for preparing medicine that is used for the treatment of female vagina and cervicitis.
At present, the medicine of treatment female vagina and cervicitis mainly contains two classes, and a class is that medicine is made suppository, and another kind of is that medicine is made tablet, is used to the intravaginal filling by patient.This two classes pharmaceutical dosage form all needs to add excipient, and the therapeutic component that these excipient influence in the medicine directly contacts with the inflammation wound surface, thereby has reduced the curative effect of therapeutic component, and easily pollutes underwear again.
The present invention designs for the effect that improves treatment female vagina and cervicitis.
According to tcm theory, female vagina and cervicitis are referred to as " leukorrheal diseases ", and the traditional Chinese medical science is thought: " leukorrheal diseases " main diseases is because of being: " invade in the damp, accumulate and give birth to heat.Chinese medicine to the Therapeutic Principle of " leukorrheal diseases " is: based on damp eliminating, and the suitable heat-clearing and toxic substances removing of holding concurrently.To have cervix uteri to waste mashed more in view of patient, the vulva pruritus symptom, and clinical experience proves, adds Chinese medicinal herbs with removing the necrotic tissue and promoting granulation, the Chinese crude drug of holding back wound and killing parasites for relieving itching, can strengthen therapeutic effect.
The technology of the present invention solution:
The present invention is made up of following Chinese medicinal herbs: Fructus Cnidii, Rhizoma Coptidis, Radix Sophorae Flavescentis, Cortex Pseudolaricis, Folium Caryophylli, dry Alumen, CATECHU, Realgar, Fel Ursi.
The present invention prepares as follows:
The first step: Fructus Cnidii and Folium Caryophylli adopt water to do the leaching solvent respectively, adopt infusion process, and decocting method or percolation will be condensed into thick paste (1) after the leachate filtration.Rhizoma Coptidis and Radix Sophorae Flavescentis adopt water to add the acid adjuvant that leaches respectively and do the leaching solvent, heating extraction, and extracting liquid filtering, adding alkali adjustment filtrate pH value such as calcium carbonate or sodium hydroxide is 7, leaves standstill a few hours, is condensed into thick paste (2) and (3) after filtering once more.Cortex Pseudolaricis as leaching solvent, adopts infusion process or hot infusion process with 40-80% ethanol, and after leachate filtered, the ethanol with in the way of distillation recovery filtrate was condensed into leachate thick paste (4) again.
Second step: after above-mentioned thick paste (1), (2), (3), (4) mixing, can adopt hypobaric drying method, medicated powder A is pulverized, is screened into to thermal vapor stream seasoning or freeze-drying drying.Dry Alumen, CATECHU and Realgar mix the back pulverizes, and is screened into medicated powder B.Fel Ursi is ground into fine powder, and the back of sieving becomes medicated powder C.
The 3rd step:, adopt eo sterilization method, far infrared sterilization or Co with medicated powder A, B, the mutual mix homogeneously of C 60The radiation sterilization sterilization all can.
Ill women can adopt China's No. 92200616.4 patents---drug powder applying device for cervix, directly sprays on the cervix uteri compound Qingdaisan powder and intravaginal, also can spray on the cervix uteri compound Qingdaisan powder and intravaginal by other people.
Adopt the present invention to treat female vagina and cervicitis is obtained following good effect: not add on the compound Qingdaisan powder of any excipient on cervix uteri and after on the intravaginal inflammatory wound surface, can contact with whole inflammatory wound surface immediately, can bring into play the anti-inflammation of medicine rapidly fully, promote the effect of planing surface healing.Nine flavor Chinese medicinal herbs pharmacological action complementations have increased antibacterial range, have strengthened antibiotic parasiticidal effect, have removing the necrotic tissue and promoting granulation again, hold back the effect of wound, have improved the scorching and various colpitic therapeutic effect of woman cervix uteri significantly.
The embodiment of the invention:
One, take off and state Chinese medicinal herbs, can prepare by following proportioning:
Fructus Cnidii 200kg Rhizoma Coptidis 150kg Radix Sophorae Flavescentis 200kg Cortex Pseudolaricis 100kg
Folium Caryophylli 100kg dry Alumen 10kg CATECHU 8kg Realgar 6kg
Fel Ursi 2kg
Two, compound Qingdaisan powder preparation method:
The first step: Fructus Cnidii and Folium Caryophylli add water 8-10 doubly, decoct twice, decoct 40-10 minute at every turn, and gradation filters, merging filtrate, and filtrate is concentrated into relative density and is: the thick paste of 1.20-1.25 (1).Add 8-10 after the Radix Sophorae Flavescentis fragmentation and doubly measure 0.2% sulfuric acid solution, heating extraction twice, each about 1 hour, merging filtrate was 7 with 10% sodium hydroxide solution adjust pH, left standstill 2 hours, filtered, filtrate is concentrated into the thick paste that relative density is 1.20-1.25 (2).Add the 0.1 % citric acid soln that 8-10 doubly measures after the Rhizoma Coptidis fragmentation, heating extraction twice, each about 1 hour, merging filtrate, using calcium carbonate or sodium hydroxid adjustment pH value is 7, leaves standstill 2 hours, filter, it is 1.12-1.22 thick paste (3) that filtrate is concentrated into relative density.Add 5 times of amount 75% alcoholic solution after the Cortex Pseudolaricis shredding, put in 40 ℃ of hot water lixiviate 48 hours, incline and get supernatant, residue adds doubly 75% ethanol of 1-2 again, put in 40 ℃ of hot water lixiviate 48 hours, and filtered, filtrate and the merging of above-mentioned supernatant, reclaim ethanol to there not being the alcohol flavor with the way of distillation, be condensed into the thick paste that relative density is 1.20-1.25 (4).
Second step: after above-mentioned thick paste (1), (2), (3), (4) mixing, adopt the hypobaric drying method drying, pulverize, cross 100 mesh sieves, become medicated powder A.Dry Alumen, CATECHU and Realgar mix the back pulverizes, and crosses 100 mesh sieves, becomes medicated powder B.Fel Ursi is ground into fine powder, crosses 100 mesh sieves, becomes medicated powder C.
The 3rd step: with medicated powder A, B, the mutual mix homogeneously of C, put in 80 ℃ of far infrared casees, dry sterilization 2 hours is crossed 100 mesh sieves, and is aseptic subpackaged by each consumption 0.6g~1.0g, and sealing promptly.

Claims (1)

1. the preparation method of a compound Qingdaisan powder is characterized in that:
Form by the following raw materials according medicine: Fructus Cnidii 200kg, Rhizoma Coptidis 150kg, Radix Sophorae Flavescentis 200kg, Cortex Pseudolaricis 100kg, Folium Caryophylli 100kg, dry Alumen 10kg, CATECHU 8kg, Realgar 6kg, Fel Ursi 2kg;
Preparation as follows:
The first step: Fructus Cnidii and Folium Caryophylli adopt water to do the leaching solvent respectively, adopt infusion process, and decocting method or percolation after leachate filtered, are concentrated into relative density and are: the thick paste 1 of 1.20-1.25; Add 8-10 after the Radix Sophorae Flavescentis fragmentation and doubly measure 0.2% sulfuric acid solution, heating extraction twice, each about 1 hour, merging filtrate, transferring pH value with 10% sodium hydroxide solution is 7, leaves standstill 2 hours, filters, filtrate is concentrated into the thick paste 2 that relative density is 1.20-1.25; Add the 0.1% citric acid solution that 8-10 doubly measures after the Rhizoma Coptidis fragmentation, heating extraction twice, each about 1 hour, merging filtrate, using calcium carbonate or sodium hydroxide adjustment pH value is 7, leaves standstill 2 hours, filter, filtrate is concentrated into relative density and is: the thick paste 3 of 1.12-1.22; 75% alcoholic solution that adds 5 times of amounts after the Cortex Pseudolaricis shredding, put lixiviate 48 hours in the 40 degree hot water, incline and get supernatant, residue adds doubly 75% ethanol of 1-2 again, put lixiviate 48 hours in the 40 degree hot water, filter, filtrate and the merging of above-mentioned supernatant, reclaim ethanol to there not being the alcohol flavor with the way of distillation, being condensed into relative density is the thick paste 4 of 1.20-1.25;
Second step: after above-mentioned thick paste 1,2,3,4 mixing, adopt hypobaric drying method, thermal vapor stream seasoning or freeze-drying drying are pulverized, and cross 100 mesh sieves, become medicated powder A; Dry Alumen, CATECHU and Realgar mix the back pulverizes, and crosses 100 mesh sieves, becomes medicated powder B; Fel Ursi is ground into fine powder, crosses 100 mesh sieves, becomes medicated powder C;
The 3rd step: with medicated powder A, B, the mutual mix homogeneously of C, put in 80 ℃ of far infrared casees, dry sterilization 2 hours is crossed 100 mesh sieves promptly.
CN93121590A 1993-12-27 1993-12-27 Method for preparation of compound Qingdaisan powder Expired - Fee Related CN1043406C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN93121590A CN1043406C (en) 1993-12-27 1993-12-27 Method for preparation of compound Qingdaisan powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN93121590A CN1043406C (en) 1993-12-27 1993-12-27 Method for preparation of compound Qingdaisan powder

Publications (2)

Publication Number Publication Date
CN1094964A CN1094964A (en) 1994-11-16
CN1043406C true CN1043406C (en) 1999-05-19

Family

ID=4993748

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93121590A Expired - Fee Related CN1043406C (en) 1993-12-27 1993-12-27 Method for preparation of compound Qingdaisan powder

Country Status (1)

Country Link
CN (1) CN1043406C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075844A3 (en) * 2003-02-26 2005-07-07 Unigen Pharmaceuticals Inc Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions
WO2005020932A3 (en) * 2003-09-02 2005-07-28 Unigen Pharmaceuticals Inc Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US7514469B2 (en) 2002-04-30 2009-04-07 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
US7695743B2 (en) 2002-04-30 2010-04-13 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8790724B2 (en) 2003-04-04 2014-07-29 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
US8945518B2 (en) 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115282194A (en) * 2022-07-28 2022-11-04 陕西康惠制药股份有限公司 Preparation method of traditional Chinese medicine composition for clearing heat, removing dampness, killing parasites and relieving itching

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《云南中医杂志》1982,3(5) 1982. 5.30 滴虫外洗方 *
《云南中医杂志》1982,3(5) 1982. 5.30 滴虫外洗方;《云南中医杂志》1982,3(5) 1982. 5.30 霉菌外洗方 *
《云南中医杂志》1982,3(5) 1982. 5.30 霉菌外洗方 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124134B2 (en) 2002-03-22 2012-02-28 Unigen, Inc. Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia
US9168242B2 (en) 2002-03-22 2015-10-27 Unigen, Inc. Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia
US8568799B2 (en) 2002-03-22 2013-10-29 Unigen, Inc. Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US7514469B2 (en) 2002-04-30 2009-04-07 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
US7695743B2 (en) 2002-04-30 2010-04-13 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8652535B2 (en) 2002-04-30 2014-02-18 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US9370544B2 (en) 2002-04-30 2016-06-21 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US9849152B2 (en) 2002-04-30 2017-12-26 Unigen, Inc. Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
US7531521B2 (en) 2003-02-26 2009-05-12 Unigen Pharmaceuticals, Inc. Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions
WO2004075844A3 (en) * 2003-02-26 2005-07-07 Unigen Pharmaceuticals Inc Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions
JP2006519231A (en) * 2003-02-26 2006-08-24 ユニゲン・ファーマシューティカルス・インコーポレーテッド Formulations for the prevention and treatment of carbohydrate-induced diseases and conditions
US8790724B2 (en) 2003-04-04 2014-07-29 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
WO2005020932A3 (en) * 2003-09-02 2005-07-28 Unigen Pharmaceuticals Inc Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments

Also Published As

Publication number Publication date
CN1094964A (en) 1994-11-16

Similar Documents

Publication Publication Date Title
CN1043406C (en) Method for preparation of compound Qingdaisan powder
CN104013929B (en) Rheumatism pain relief medicine for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof
CN102772712A (en) Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot
CN104840695A (en) Medicine combination for treating white scour of piglet and preparation method thereof
CN103736017A (en) Traditional Chinese medicine composition for treating intercostal neuralgia and preparation method of traditional Chinese medicine composition
CN1742904A (en) Chinese medicine for treating urinary stone and urinary system inflammation, and production method thereof
CN104042765A (en) Medicine for promoting postoperative fracture recovery and preparation method of medicine
CN1351872A (en) Chinese herbal medicine for curing comedo and acne
CN1050054C (en) Fugong granule for postpartum disease
CN104069443A (en) Traditional Chinese medicine for treating acute purulent osteomyelitis and preparation method of traditional Chinese medicine
CN103845616A (en) Pharmaceutical composition for eliminating inflammation and disinfecting
CN105395686A (en) Folium artemisiae argyi-containing pharmaceutical preparation for treating vaginal bleeding and preparing method thereof
CN103751396B (en) External medical composition for treating gonarthromeningitis
CN105148147A (en) Traditional Chinese medicine for treating wound or bedsore infection and preparation method thereof
CN102755519B (en) Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof
CN102274353A (en) Traditional Chinese preparation for treating ulcers
CN105456624A (en) Traditional Chinese medicine caring composition for post-partum recovery and preparation method thereof
CN100506219C (en) Notoginseng hemostatic and its preparing method
CN103142958A (en) Medicament for treating perniosis
CN102631587B (en) Chinese herbal medicinal composition for treating condyloma acuminatum and preparation method thereof
CN1158093C (en) Medicine composition containing yak bone for treating rhenmatism and method for making same
CN103463287A (en) Novel method for preparing anti-hyperosteogeny tablet
CN115645508B (en) External traditional Chinese medicine composition and external preparation for cervical diseases and preparation method thereof
CN1175837C (en) Antiphlogistic honeysuckle flower tablet and its making process
CN106309636B (en) Pharmaceutical composition for uterine bleeding

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee